Prion-like mechanisms in the pathogenesis of tauopathies and synucleinopathies.
about
Prions, prion-like prionoids, and neurodegenerative disordersConfocal Spectroscopy to Study Dimerization, Oligomerization and Aggregation of Proteins: A Practical GuideThe preclinical phase of the pathological process underlying sporadic Alzheimer's diseaseThe Role of MAPT in Neurodegenerative Diseases: Genetics, Mechanisms and TherapyAffinity of Tau antibodies for solubilized pathological Tau species but not their immunogen or insoluble Tau aggregates predicts in vivo and ex vivo efficacy.Are cases with tau pathology occurring in the absence of Aβ deposits part of the AD-related pathological process?PART is part of Alzheimer disease.pH-Driven Polymorphism of Insulin Amyloid-Like Fibrils.Neuronal uptake and propagation of a rare phosphorylated high-molecular-weight tau derived from Alzheimer's disease brain.TDP-43 is intercellularly transmitted across axon terminalsPropagation of pathological α-synuclein in marmoset brain.Gastrointestinal Biopsies for the Diagnosis of Alpha-Synuclein Pathology in Parkinson's Disease.Review: Sporadic Parkinson's disease: development and distribution of α-synuclein pathology.Key Points Concerning Amyloid Infectivity and Prion-Like Neuronal InvasionAnti-tau antibody administration increases plasma tau in transgenic mice and patients with tauopathy.Vagal neurocircuitry and its influence on gastric motilityMolecular changes in the postmortem parkinsonian brain.Potential Pathways of Abnormal Tau and α-Synuclein Dissemination in Sporadic Alzheimer's and Parkinson's Diseases.Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies.Nanomolar oligomerization and selective co-aggregation of α-synuclein pathogenic mutants revealed by single-molecule fluorescence.Prion-like proteins and their computational identification in proteomes.O-GlcNAc cycling and the regulation of nucleocytoplasmic dynamics.Secretory carrier membrane protein 5 is an autophagy inhibitor that promotes the secretion of α-synuclein via exosome.Polymorphism of amyloid-like fibrils can be defined by the concentration of seeds.Tau Protein in Oral Mucosa and Cognitive State: A Cross-sectional Study.Reduced Abundance and Subverted Functions of Proteins in Prion-Like Diseases: Gained Functions Fascinate but Lost Functions Affect Aetiology.The Presence of Select Tau Species in Human Peripheral Tissues and Their Relation to Alzheimer's Disease.A 31-residue peptide induces aggregation of tau's microtubule-binding region in cells.CNS Injury: Posttranslational Modification of the Tau Protein as a Biomarker.Does traumatic brain injury hold the key to the Alzheimer's disease puzzle?A Nigro-Vagal Pathway Controls Gastric Motility and Is Affected in a Rat Model of Parkinsonism.FRET and Flow Cytometry Assays to Measure Proteopathic Seeding Activity in Biological Samples.Propagation of alpha-synuclein pathology from the olfactory bulb: possible role in the pathogenesis of dementia with Lewy bodies.Protein Misfolding in Prion and Prion-Like Diseases: Reconsidering a Required Role for Protein Loss-of-Function.Unravelling the inhibitory activity of Chlamydomonas reinhardtii sulfated polysaccharides against α-Synuclein fibrillation.The Synergy of Aging and LPS Exposure in a Mouse Model of Parkinson's Disease
P2860
Q26747002-BCF78E78-7E34-4072-A0E2-4FFC39547063Q26752808-847C4E6C-D316-4AFC-8A68-FCA917E53A73Q28083428-590136C7-8C84-4252-8EC7-3A6F5F0F70ABQ28119005-34CACDFF-2847-497D-9A85-5D8FE05FE7A9Q30805841-AAE2EA49-7355-43A0-8EA8-A3969C91A67EQ34445601-3426E594-CF61-4C60-9724-C42C74B09E24Q34460027-6D577766-C53C-4904-BCA9-F1F2F3B22B3DQ35757446-65368C87-9105-4815-A1EF-82B0D7035435Q36169754-3E6764DB-05FB-42D0-A906-3F135D6E2698Q36310560-A19968C7-5499-4601-BB76-18236B15804AQ37621023-9ECFDB42-A2CE-4A93-846C-B23602C7AF10Q38528899-1D7BE848-2197-4E4C-B777-5BC4C96CCDFAQ38667942-D59220EC-8273-46B9-A7B7-2A81F38640BFQ38826332-1D90FA27-0522-40BA-BAA4-316178F3C295Q38829673-2A074AC9-6164-45FF-8DA0-0A5C73685996Q38850684-3BEAC8DE-ECE4-4FB7-BB8B-7DDB32D387B9Q38887346-062A7304-58CD-4D62-8B5B-34E471E9D5DDQ38942540-B0F34233-5BAA-4C70-ABF4-2FE16CF6A6B3Q39021126-613386A7-9A5A-419C-A310-D3351B6DB707Q39149504-51D85B01-7338-4514-A377-32BA2FE39857Q39167900-BDC5955C-45CB-4EAE-9867-3B83CA23D654Q39241505-DB8172C5-5DAE-401F-A4D0-CAE9E14E2371Q40995496-ADB7F9FB-8D27-4F91-A449-35C9763AD019Q41007140-A34B75DA-CE43-47F1-9BDC-A7B88908E8E2Q42683308-A81F8C59-1800-40A9-8D1B-E5CC777447F7Q44607866-FAE1A1C4-4BAA-4E71-960D-049F53344E8AQ46593984-E8EBAE22-AEF5-40B0-B81F-C8E24B5FC054Q46651347-43EA7A47-0160-4422-9E32-E01D0CB83700Q47250204-85928B25-0201-4D7F-8D14-2E962E799A6CQ47677964-6391D01F-03FA-4F6B-A0EE-88BF042E4FB6Q47799983-0A620E11-C0B4-454A-B703-3FAFCA4A8A46Q48395274-5FD04D04-8665-4066-A620-20851B6B87A2Q49353206-AECE4E4F-1B0D-4151-A458-07460A0A0BD8Q51653976-8221A3BB-C914-4134-BBD2-08F968E1BD02Q55222924-CE38940C-78DB-406F-939E-87F2586DADAAQ57051340-1527FD09-FE47-471A-83B7-17A7C2430A34
P2860
Prion-like mechanisms in the pathogenesis of tauopathies and synucleinopathies.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Prion-like mechanisms in the pathogenesis of tauopathies and synucleinopathies.
@en
type
label
Prion-like mechanisms in the pathogenesis of tauopathies and synucleinopathies.
@en
prefLabel
Prion-like mechanisms in the pathogenesis of tauopathies and synucleinopathies.
@en
P2093
P2860
P1476
Prion-like mechanisms in the pathogenesis of tauopathies and synucleinopathies.
@en
P2093
Ben Falcon
Florence Clavaguera
Markus Tolnay
Michel Goedert
P2860
P2888
P356
10.1007/S11910-014-0495-Z
P577
2014-11-01T00:00:00Z
P5875
P6179
1003460490